
1. Technology overview
Frekil is a San Francisco startup from Y Combinator's Spring 2025 batch, founded in 2025. Its homepage now presents an AI platform for real-world evidence (RWE), covering post-marketing safety, HEOR and comparative effectiveness studies that drug makers need after approval.
The platform connects to EHR, claims or registry data, accepts study questions in natural language and designs target trial emulations on a causal graph. Protocols and statistical analysis plans are locked before data is touched, the AI writes code but not results, and every number traces to code and data. It runs in the customer's cloud, including Databricks or Snowflake.
2. Highlighted features & specifications
- Post-authorisation safety: supports PASS commitments and safety signal follow-up.
- Comparative effectiveness: designs target trial emulations for payers and HTA bodies.
- External comparators: builds real-world comparator arms for single-arm trials.
- Natural-language study start: structures questions and queries EHR, claims or registries.
- Audit trail: records every change, decision and sign-off.
- Reporting: produces study reports mapped to STROBE, RECORD and ICH M14.
3. Potential application
A pharma company could run a post-marketing safety study on hospital data. A university hospital could emulate a target trial on its own EHR. A payer could request comparative-effectiveness evidence for reimbursement dossiers.
4. Benefits
Studies follow a protocol locked before data access, which avoids p-hacking. Each result links to code, data or literature. Changes and sign-offs are logged with 21 CFR Part 11-aligned controls. Patient data stays in the customer's cloud.
5. Market trends & opportunities
Regulators and HTA bodies increasingly ask for real-world evidence after approval, and manual epidemiology workflows are slow. Pharma firms look for auditable AI instead of general chat tools. Hospital research units in Southeast Asia are building local evidence on EHR data.
6. Other information
Frekil; San Francisco, USA; founded 2025; Y Combinator Spring 2025. The 2025 launch post described a medical-scan annotation product; the current site describes the RWE platform.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































